Try our beta test site
3302 studies found for:    electrocardiogram
Show Display Options
Rank Status Study
21 Completed Double-Blind Randomized Crossover Trial to Access Electrocardiogram Effects of HPN-100
Condition: Drug Toxicity
Interventions: Drug: HPN-100;   Drug: HPN-100 or Placebo;   Drug: Placebo;   Drug: Moxifloxacin
22 Terminated Evaluation of a Non-Invasive Electrocardiogram-Assisted Blood Pressure Monitor
Conditions: Hypertension;   Atrial Fibrillation;   Obesity;   Heart Failure;   Atherosclerosis
23 Completed Quantification of Autonomic Nervous Activity During Hemodialysis
Condition: Chronic Kidney Disease on Hemodialysis
Intervention: Other: Analysis of the holter electrocardiogram
24 Recruiting Paced Electrocardiogram Requiring Fast Emergent Coronary Therapy (PERFECT) Study
Condition: Acute Myocardial Infarction
25 Withdrawn A Study to Evaluate the Effect of GSK1322322 on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers
Condition: Infections, Bacterial
Interventions: Drug: GSK1322322 1200 mg;   Drug: GSK1322322 3000 mg;   Drug: Placebo;   Drug: Moxifloxacin
26 Terminated Fetal Electrocardiogram Extraction-Pilot Study
Condition: Pregnancy
27 Recruiting Intracardiac Flow Remodeling in Athletes
Condition: Cardiac Remodeling, Ventricular
Intervention: Other: electrocardiogram and echocardiography
28 Completed Reha Drive: Capacitive Electrocardiography in Car Seat in Cardiological Patients
Condition: Cardiac Events
Intervention: Other: Capacitive ECG and contactless heart and breathing rate measurements via camera
29 Terminated
Has Results
Electrocardiogram (ECG) Guided Peripherally Inserted Central Catheter (PICC) Placement
Condition: Primary Focus: Adult Subjects Who Require PICC Placement
Intervention: Device: ECG-guided PICC placement
30 Withdrawn Electrocardiography Versus Pulse Oximetry for Newborn Heart Rate Determination
Condition: Prematurity
Intervention: Device: Apparatuses
31 Completed A Study to Evaluate the Effects of JNJ-54861911 on Electrocardiogram Intervals in Healthy Particiants
Condition: Healthy
Interventions: Drug: JNJ-54861911-Therapeutic Dose;   Drug: JNJ-54861911 - Supratherapeutic Dose;   Drug: JNJ-54861911-Matched Placebo;   Drug: Moxifloxacin;   Drug: Moxifloxacin Matched Placebo
32 Recruiting Multicentre Investigation of Novel Electrocardiogram Risk Markers in Ventricular Arrhythmia Prediction
Conditions: Ventricular Arrythmia;   Ischemic Cardiomyopathy
33 Completed Pre-Hospital Wireless Transmission of Electrocardiograms to a Cardiologist Via a Hand-Held Device
Condition: Myocardial Infarction
Intervention: Device: SmartLink Wireless Monitoring System (K033642)
34 Unknown  Time Frequency Analysis of Electrocardiogram and Blood Pressure in Intracranial Hemorrhage Patients
Conditions: Subarachnoid Hemorrhage;   Intracranial Hemorrhages;   Cerebral Hemorrhage
35 Recruiting Clinical Data Validation of Novel Wireless Cortrium C3 Monitor for Continuous Electrocardiogram Measurements
Condition: Atrial Fibrillation
Interventions: Device: Cortrium C3 device;   Device: Holter device
36 Completed Markers of Paroxysmal Atrial Fibrillation in Esophageal Holter Electrocardiography
Conditions: Atrial Fibrillation;   Atrial Premature Complexes
37 Recruiting Effect of Antenatal SSRI Exposure on the QT Interval of Neonates
Conditions: Qt Interval, Variation in;   Adverse Effect of Selective Serotonin Reuptake Inhibitors
Intervention: Procedure: Electrocardiogram
38 Completed Study to Define the Electrocardiogram Effects of a Single Dose of LX4211 in Healthy Subjects
Condition: Healthy
Interventions: Drug: LX4211 800 mg;   Drug: LX4211 2000 mg;   Drug: moxifloxacin 400 mg;   Drug: LX4211 Placebo
39 Completed Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy Subjects
Condition: Healthy Subjects
Interventions: Drug: exenatide;   Drug: Moxifloxacin;   Drug: Placebo
40 Completed Characterization of Ischemia Related Changes in Esophageal Electrocardiography
Condition: Coronary Artery Disease
Intervention: Procedure: Measurement of coronary collateral flow index

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.